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Abstract
Current available secondary dose calculation software for Gamma Knife radiosurgery
falls short in situations where the target is shallow in depth or when the patient is
positioned with a gamma angle other than 90°. In this work, we evaluate a new secondary calculation software which utilizes an innovative method to handle nonstan-
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dard gamma angles and image thresholding to render the skull for dose calculation.
800 treatment targets previously treated with our GammaKnife Icon system were
imported from our treatment planning system (GammaPlan 11.0.3) and a secondary
dose calculation was conducted. The agreement between the new calculations and
the TPS were recorded and compared to the original secondary dose calculation
agreement with the TPS using a Wilcoxon Signed Rank Test. Further comparisons
using a Mann‐Whitney test were made for targets treated at a 90° gamma angle
against those treated with either a 70 or 110 gamma angle for both the new and
commercial secondary dose calculation systems. Correlations between dose deviations from the treatment planning system against average target depth were evaluated using a Kendall’s Tau correlation test for both programs. The Wilcoxon Signed
Rank Test indicated a signiﬁcant difference in the agreement between the two secondary calculations and the TPS, with a P‐value < 0.0001. With respect to patients
treated at nonstandard gamma angles, the new software was largely independent of
patient setup, while the commercial software showed a signiﬁcant dependence (P‐
value < 0.0001). The new secondary dose calculation software showed a moderate
correlation with calculation depth, while the commercial software showed a weak
correlation (Tau = −.322 and Tau = −.217 respectively). Overall, the new secondary
software has better agreement with the TPS than the commercially available secondary calculation software over a range of diverse treatment geometries.
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1 | INTRODUCTION

ET AL.

is calculated for Icon patients using the TMR10 algorithm.17 This
algorithm requires only dose rate calibration given by the user and a

Gamma Knife (GK) radiosurgery has become a popular technique for

conﬁgurable collimator output factors that are provided by manufac-

the treatment of a variety of intracranial diseases, such as acoustic

turer. The TMR10 uses an exponential attenuation computation to

neuroma, pituitary adenoma, trigeminal neuralgia, vascular malforma-

the point of interest that is speciﬁc to each source location. The

tions, and malignant metastases.1,2 Using 192 collimated Co‐60

attenuation length (i.e. depth of the point of interest in the patient)

sources focused at an isocenter, a patient will be stereotactically

for each source is calculated based on the source focal point, the

positioned to place the target at the source ray intersections to sub-

distance from the focal point to the point of interest, and the dis-

millimeter accuracy.3 GK treatments are characterized by large doses

tance to the rendered skull surface.18 For each GK Icon target trea-

delivered in a single, or more recently, hypofractionated schemes uti-

ted, a secondary dose calculation using a commercially available

lizing rigid thermoplastic masks with cone beam CT image guidance,

software is completed prior to treatment per institution policy. This

4,5

Because of

commercial secondary check software reportedly uses the same

the uniqueness of this system and treatments, quality assurance

TMR10 dose calculation formalism as the TPS, and reconstructs the

(QA) is of the utmost importance, including patient speciﬁc sec-

patient skull using 24 scalar measurements either input directly by

ondary dose calculations.6 Secondary independent dose calculations

the user or inferred from a CT dataset.19 The same user inputs were

play an important role in radiation therapy, and given the high preci-

utilized for the second check software as the TPS. Our experience is

sion associated with GK radiosurgery, secondary dose checks

similar to Xu et al.,11 especially where the commercially available

become even more important to reduce the risk of doing serious

software performs poorly in the presence of a nonstandard gamma

harm to the patient.7,8

angle, in some cases deviating from the TPS by more than 10%. This

and very sharp dose gradients outside of the target.

Given the complicated geometry of GK treatments, establishing

known issue presents a clinical difﬁculty in that treatment cannot

an accurate methodology to incorporate secondary dose calcula-

proceed unless the TPS and secondary dose calculation agree to

tions into the clinic workﬂow has been cumbersome.8 There have

within 5%, as is the recommendation taken from AAPM Task Group

been several publications working to satisfy this clinical need, but

40 and our clinical policy.7 In many cases, the problem is circum-

many of the secondary dose calculation techniques suggested will

vented by selecting a different point in the plan other than the point

still fail in certain situations, most notably when the patient is

of maximum dose for comparison. Unfortunately, this limits the

setup with a 110 or 70° gamma angle, or when the calculation

applicability of the integral purpose of independent secondary dose

point is at a shallow depth near the skull surface. It has been sug-

calculation.

gested that these difﬁculties in accurate secondary dose calcula-

In this work, a new secondary dose calculation engine based on

tion arise from modeling the skull geometry, and constant density

the work of Mamalui‐Hunter et al.12 is evaluated and compared to a

8

assumptions near the skull surface. Different skull rendering tech-

commercially available secondary check software. The new software

niques have been proposed, including modeling the skull as a

reportedly uses the same dose calculation algorithm as described

sphere or using measured skull data from the use of a skull scalar

previously,20 but aims to solve the described deﬁciencies of previous

instrument.8–10 These methods work well for standard patient and

secondary dose calculation methods. An image threshold skull ren-

target geometries, but signiﬁcant discrepancies from the treatment

dering technique is utilized, and the gamma angle is precisely

planning system (TPS) are still evident when the target is at a

accounted for by applying a rotation matrix for each beamlet directly

shallow depth or when the patient setup uses a non 90° gamma

in the new software. Beamlets are created at each source position

11

It has been suggested that using an image thresholding

for each shot in each target. The beamlets themselves are then

technique may be the best method to accurately construct the

rotated and translated in space according to shot geometry, including

patients skull for dose calculation.12 Image thresholding makes use

gamma angle considerations. With the beamlets in their proper geo-

of an image data set such as CT or MRI and binarily assigns a

metric positions about the skull, the vectors from source to isocenter

voxel of the dataset to be within or beyond the skull boundary

and calculation point are ray traced through patient geometry for

based upon a determined threshold image scale value. Skull ren-

depth calculations to compute dose.

angle.

dering using this method minimizes uncertainties from measure-

The combination of these two methods may result in more accu-

ment interpolation and produces an accurate representation of the

rate calculation conditions for both standard and nonstandard

true patient surface geometry.

gamma angles which in turn will provide a more robust secondary

Our institution installed the Leksell Gamma Knife Icon (Elekta

calculation engine that can be used in the clinical setting.

Medical Systems, Stockholm, Sweden) in November of 2017. The
Icon treatment system utilizes 192 Co‐60 sources divided into eight
sectors that can be individually blocked, or collimated to 4, 8, and

2 | MATERIALS AND METHODS

16 mm shot sizes. The Icon is unique in that it utilizes on‐board cone
beam computed tomography (CBCT) imaging system to enable frac-

To evaluate the new secondary dose calculation software (Radcalc,

tionated and frameless treatments.13 The speciﬁcs on commissioning

Lifeline Software, Austin, TX) after the review and approval from the

and QA for the Icon system can be found in the literature.13–16 Dose

Institutional Review Board (HRPO# 201904138), the ﬁrst 800
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targets treated since the Icon’s installation at our institution were

was completed using a Kendall’s Tau correlation test to evaluate any

exported from our treatment planning software (TPS) (GammaPlan

dependencies the secondary software has on target location depth

11.0.3, Elekta Medical Systems, Stockholm, Sweden) to the new sec-

in the skull. The target cohort was then binarily categorized by

ondary calculation patient database. These 800 targets were a sufﬁ-

gamma angle (standard 90° and nonstandard 70/110°). Using a

cient representative of the patient population that is typically

Mann‐Whitney U test, differences between the two categories with

treated at our institution. Target positions ranged from the periphery

respect to agreement with the TPS were evaluated for statistical sig-

of the skull to more central locations. This resulted in a wide range

niﬁcance.

of average calculation depths, from 2.4 to 10.5 cm. The target popu-

A Wilcoxon Signed Rank Test (WSRT) was used to evaluate sig-

lation used in this study also included a variety of non‐standard

niﬁcant differences in the deviation from the TPS calculated dose

patient setup geometries where a gamma angle of 70 or 110° was

over the entire 800 treatment targets for both calculation software

utilized (30 cases).

packages. Using the same techniques as described for the new sec-

After each target was imported into the new secondary calcula-

ondary dose calculation software, dependencies on agreement to the

tion software, the patient skulls were constructed using the image

TPS of the commercially available software dose calculation as it

thresholding technique, in contrast with the derived scalar measure-

pertains to gamma angle and average calculation depth were evalu-

ments used in the commercial software (Gamma Check, MU Check,

ated and compared to the dependencies of the new secondary dose

Oklahoma City, OK), available with the program (Fig. 1). In most

calculation software.

cases, the skulls were rendered from a CT image dataset. However,

The new secondary dose calculation software has the capabil-

in approximately 10% of the patient plans a CT dataset was not

ity to render the skull for dose calculation using discrete scalar

available and the patient’s skull was rendered using an MRI dataset.

measurements if these measurements were used in the TPS for

The current versions of the TPS support image thresholding skull

planning. To isolate the robustness of the beamlet rotation

deﬁnition from both types of imaging modalities. Individual beamlet

algorithm employed for nonstandard gamma angles by the new

rotations were also made for patient setups using non‐standard

software, the target with a nonstandard gamma angle patient

gamma angles. Dose was re‐calculated with the new software, and

setup that showed the largest discrepancy from the TPS by the

the agreement to the TPS was evaluated. This was done using the

commercially available software was replanned in GammaPlan

percent difference for each individual target. The median and range

using skull scalar measurements. The plan was reimported to the

of the percent differences per target was calculated over the entire

new software and the skull was rendered using the discrete mea-

cohort. A further comparison of deviation between TPS and sec-

surements. Dose was recalculated using the new software and

ondary calculation doses with respect to average calculation depth

compared with the TPS.

F I G . 1 . Top: A reconstructed phantom
skull surface geometry using the image
thresholding technique from the new
secondary calculation software for a head
phantom. Bottom: A reconstructed
phantom skull surface geometry using
scalar measurements from the commercial
software.
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F I G . 2 . The absolute percent differences from the TPS for each of the 800 targets calculated using the new secondary dose check software
and the commercially available secondary dose calculation software. TPS, treatment planning system.

As the purpose for a secondary dose calculation is to give the

deviations between the new and commercially available secondary

user conﬁdence that the primary dose calculation from the TPS is

dose calculations, with a P‐value < 0.0001, where the overall agree-

accurate, an absolute dose measurement was also employed for

ment between the new secondary dose calculation software and the

comparison against both the TPS and the two secondary dose calcu-

TPS was superior as shown in Fig. 3.

lation engines. In the two plans where the TPS estimated dose and

With respect to the secondary dose calculation dependency on

the commercially available secondary dose software differed the

average calculation depth, the Kendall’s Tau correlation test showed

greatest, the shot arrangement and gamma angle in the patient plan

that a moderate (tau = −.322), and weak (tau = −.217) inverse corre-

was copied to an anthropomorphic phantom and a ﬁlm measurement

lation exists between calculated dose discrepancy from the TPS and

was taken. Using EBT3 gafrchormic ﬁlm cross calibrated to an ADCL

calculation depth for the new secondary dose calculation software

calibrated ionization chamber, an optical density to dose calibration

and the commercially available software, respectively, shown in

curve was created by irradiating a 16 mm shot to 2, 3, 4 and 5 Gy.

Fig. 4. This suggests that for the new secondary dose calculation

Next, the patient plan was scaled to a max dose of 4 Gy, and deliv-

software, the discrepancy in calculated dose from the TPS may

ered on an anthropomorphic head phantom. The maximum measured

increase slightly for targets at shallower depth, however, for the

dose was then compared to the TPS, a calculation from commercially

commercial software the depth does not seem to correlate well with

available software, and what the new secondary dose calculation

percent difference.

software predicted. Each of the ﬁlm measurements, including calibration ﬁlms, were repeated three times.

The gamma angle does not appear to play a large role in the calculated dose agreement between the new secondary dose calculation software and the TPS. When compared to dose deviations from
the TPS at a gamma angle of 90°, the discrepancies from the TPS at

3 | RESULTS

gamma angles of 70/110° were not signiﬁcant (P‐value = 0.102). This
is in contrast with what was seen with the commercially available

Over the entire target cohort, the new secondary dose calculation

calculation software, where the discrepancies between dose calcula-

software showed excellent agreement with the TPS. The differences

tions were signiﬁcant for standard vs nonstandard gamma angles

from the TPS ranged from 0.00% to 3.33%, with a median and mean

(P < 0.0001), shown in Fig. 5. When looking at dose deviations for

value of 0.6% and 0.68%, respectively, which is well within our clini-

gamma angles of 90° only, the new secondary calculation software

cal tolerance. The agreement between the TPS and the commercially

showed signiﬁcantly smaller deviations from the TPS when com-

available dose calculation software showed larger deviations, ranging

pared to the commercial software (P < 0.0001).

from 0.00% to 10.25% and a median and mean value of 0.833% and

The largest deviation from the TPS calculated dose using the

1.15%, with 13 above clinical tolerance. These data are shown in

commercially available secondary software was 10.25%. This particu-

Fig. 2. The WSRT revealed a signiﬁcant difference in the agreement

lar plan had a nonstandard gamma angle of 70°. The corresponding
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F I G . 3 . A box and swarm plot of the
absolute differences from the TPS and the
Wilcoxon Signed Rank Test for each of the
800 targets using the commercial and new
secondary dose calculation software. TPS,
treatment planning system.

F I G . 4 . The results of the Kendall’s tau correlation evaluation. The absolute percent difference from the TPS for the new software shows a
moderate correlation with average calculation depth (tau = −0.322). The absolute percent difference from the TPS for the commercial software
shows a weak correlation with average calculation depth (tau = −0.217). TPS, treatment planning system.

point with the new check software using image threshold skull ren-

In the two cases where the commercial secondary calculation

dering was 1.3 percent. The new secondary calculation software has

and the TPS differed the greatest, one target utilized a gamma angle

the capability to construct the skull for calculation using scalar mea-

of 70° in the plan, while the other had a gamma angle of 110°.

surements, assuming the skull was constructed this way in the TPS.

When these target plans were replanned on the anthropomorphic

To isolate how the two secondary calculation engines compare to

phantom to a maximum dose of 4 Gy, the commercial and new sec-

the TPS when both use scalar measurements for skull rendering, this

ondary dose calculated a max dose of 4.36 Gy (9.2% higher than the

plan was recalculated in Gamma Plan with skull scalar measurements

TPS) and 4.047 Gy (1.2% higher than the TPS) for the 70° gamma

(as opposed to an image dataset) and a secondary dose check was

angle plan and 4.39 Gy (9.1% higher than the TPS) and 4.044 Gy

repeated using both systems. When recalculated in the new soft-

(1.1% higher than the TPS) for the 110° gamma angle plan. How-

ware using skull scalar measurements the agreement remained

ever, the ﬁlm measurement resulted in a delivered dose of 3.91 Gy

within clinical tolerance at 0.1%, the corresponding agreement using

+/− 0.04 Gy to the 70° gamma angle plan differing from the TPS by

the commercial software was still above tolerance at 6.5%.

−2.25%, and 3.88 Gy +/− 0.08 Gy to the 110° plan, differing from
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F I G . 5 . The comparison of percent
differences with regards to standard and
non‐standard gamma angle setups for both
the commercial software and the new
software. The new software does not
show a signiﬁcant dependency on gamma
angle in patient setup (P = 0.1025).
the TPS by −3%. Both the TPS and new secondary dose calculation

the new software does agree well within tolerance to the TPS and

fall well within our clinic’s 5% agreement criteria with measurement,

absolute ﬁlm dose measurement. This suggests that while the new

while the commercial secondary calculation falls well outside of the

software agrees well with the TPS, it is also independently accurate

measurement results.

in calculating dose for complex treatment plans where nonstandard
gamma angles are used in patient setup.
The gamma rotation technique of the commercial software is rela-

4 | DISCUSSION

tively unclear. The information on this topic available to the user via
vendor provided documentation provides a short summary for the

The results from this study show promising clinical applicability for

Gamma Knife model 4C, but gives little insight for the Icon.19 Based

the new secondary dose calculation software. Each of the 800 tar-

upon this documentation it appears that for the 4C, the general strat-

gets calculated are well within our clinical tolerance of 5%. The dis-

egy of translating source position with respect to gamma angle is sim-

tribution of deviations from the TPS between the commercial

ilar to the new software. However, the implementations of the

software and the new calculation software shows a signiﬁcant differ-

beamlet translation algorithm for the Icon used by the two different

ence, with the deviations being smaller for the new software. This

secondary calculation engines are not equivalent. This is apparent

shows strong evidence that the new secondary dose calculation soft-

when looking at the proﬁles of each 16 mm shot in the X, Y, and Z

ware is a robust platform for independent dose calculation that

directions for each gamma angle. Figure 6 shows a comparison of the

effectively handles complex patient setup and geometries. This is

dose proﬁles taken from the TPS, the commercial software, and the

especially true when considering the use of nonstandard gamma

new software in each plane and for gamma angles of 70, 90, and

angles for patient positioning. The commercially available software

110°. When looking at the comparison for 90° gamma angle, the

falls short in several instances where a gamma angle of 70 or 110°

agreement between the three dose calculations is exceptional. How-

is used. In fact, the Mann‐Whitney test shows a signiﬁcant differ-

ever, at the nonstandard gamma angles, there are large discrepancies

ence in the deviations from the TPS between standard and nonstan-

in the penumbra and tail regions of the proﬁles. In the X direction,

dard gamma angles for the commercially available secondary dose

the commercial software signiﬁcantly underpredicts the dose when

calculation software, conﬁrming dependency on the patient orienta-

compared to the new software and the TPS. In the Y direction, the

tion that has been previously shown in literature.11 However, the

commercial proﬁle is asymmetric compared to the other two calcula-

same comparison is not signiﬁcant for the new secondary dose cal-

tions, where one side of the proﬁle matches reasonably well, and the

culation software, indicating that the method of beamlet rotation

opposite side calculates a lower dose in comparison. In the Z direc-

matrices eliminates this dependence. This argument is further

tion, the commercial software overpredicts dose compared to the

strengthened by the skull scalar measurement example using the

other two calculation algorithms. However, in all three planes for

new calculation software, as well as by the absolute ﬁlm dose mea-

each gamma angle setup, the proﬁles of the new software and the

surement. In skull scalar measurement example, both the commer-

TPS agree well. It is likely that for this reason large discrepancies from

cially available and secondary dose software rendered the skull using

the TPS dose calculations are seen in the commercial software but

skull scalar measurements, removing the dependency on the render-

not the new secondary dose calculation software. When two or more

ing of the skull and isolating the methods used by these two pro-

shots are in close proximity with nonstandard gamma angles, the

grams to handle gamma rotations. The new software calculation was

propagation of errors in the tail regions of the proﬁles compounding

still well within tolerance, while the commercial software showed a

on the high dose area of another shot will cause a large disagreement

discrepancy of 6.5%. With regards to measurement, for the cases

between the two calculations that is not seen with the new sec-

where the commercial software disagrees signiﬁcantly from the TPS,

ondary dose calculation software.
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F I G . 6 . A comparison of the dose proﬁles for a single 16mm shot calculated using the TPS, the commercial software and the new secondary
dose calculation software. From left to right, the proﬁles are taken in X, Y and Z planes, respectively. From superior to inferior, the proﬁles are
at gamma angles of 70, 90° and 110°, respectively. For all gamma angles, the new dose calculation software and the TPS match well.
However, at gamma angles of 70 and 110°, the commercial software show discrepancies in the tail and penumbra regions. TPS, treatment
planning system.

Looking at the calculations for patients treated at 90° gamma
angles

only,

the

new

secondary

software

had

setups, these current secondary calculation methods fail, leading the

signiﬁcantly

user to make difﬁcult clinical decisions on whether to proceed with

(P < 0.0001) smaller deviations from the TPS than the commercial

treatment that may not be warranted due to the inaccuracy of sec-

software. This indicates that the imaging threshold method of skull

ondary dose calculation. In this study, a new secondary dose calcula-

rending out performs scalar measurements with interpolation, sug-

tion software for Gamma Knife radiosurgery using image threshold

gesting that a patient’s head may not always be well‐described by

skull rendering and beamlet rotation technique was evaluated and

24 scalar measurements. Rendering the skull using this image thresh-

compared to a commercially available software for 800 targets trea-

olding technique gives much more ﬂexibility for accurate calculation

ted with our Icon system. The new software clearly excels where

over a wide range of skull shapes and sizes.

the commercial software falls short, especially in the presence of

While the new software showed excellent agreement with the

110 and 70° gamma angles in patient setup. This will make a large

TPS and measurement, the calculation deviation does appear to have

impact for the Gamma Knife physicist for plan QA by providing con-

a small dependence on the average calculation depth, as shown by

ﬁdence to the user that the planned dose calculated by the TPS is

the moderate correlation in the Kendall Tau test. It is not obvious as

accurate, regardless of complexity of calculation geometry.

to what the source of this dependency is, but it could be a function
of interpolation in the 3D computation matrix to a single point dose
that is more evident at shallower depths. However, in the commer-
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